蘇州固鍀(002079.SZ):擬2055.74萬元受讓控股股東所持蘇州硅能47.139%股權
格隆匯3月25日丨蘇州固鍀(002079.SZ)公佈,為了整合及優化公司業務發展,減少關聯交易,公司擬受讓控股股東蘇州通博所持蘇州硅能半導體科技股份有限公司(簡稱“蘇州硅能”)47.139%的股權,交易對價合計2055.7382萬元。此次轉讓後,公司持有蘇州硅能股份比例將升至73.094%。
該次關聯交易的目的是通過受讓控股股東蘇州通博持有的參股公司蘇州硅能47.139%的股權,減少和蘇州硅能之間的關聯交易,同時拓展公司MOSFET系列產品在消費電子、電源等領域的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.